Cara Therapeutics
CARA
#10368
Rank
NZ$13.93 M
Marketcap
NZ$9.14
Share price
-2.56%
Change (1 day)
1,864.68%
Change (1 year)

EPS for Cara Therapeutics (CARA)

EPS in 2024 (TTM): NZ-$34.05

According to Cara Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$36.09. In 2023 the company made an earnings per share (EPS) of NZ-$44.96 a decrease over its 2022 EPS that were of NZ-$32.79.

EPS history for Cara Therapeutics from 2013 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$34.05-24.26%
2023NZ-$44.9637.11%
2022NZ-$32.79-8.09%
2021NZ-$35.68
2019NZ-$51.3520.87%
2018NZ-$42.487.85%
2017NZ-$39.39-9.05%
2016NZ-$43.31110%
2015NZ-$20.6217.65%
2014NZ-$17.53-3.42%
2013NZ-$18.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Trevena
TRVN
NZ-$59.70 65.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
NZ-$3.83-89.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.96-108.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$17.94-149.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ-$86.46 139.57%๐Ÿ‡บ๐Ÿ‡ธ USA